Thomas W. Dubensky - Net Worth and Insider Trading
Thomas W. Dubensky Net Worth
The estimated net worth of Thomas W. Dubensky is at least $534,744 dollars as of 2024-05-06. Thomas W. Dubensky is the President of Tempest Therapeutics Inc and owns about 113,343 shares of Tempest Therapeutics Inc (TPST) stock worth over $418,236. Thomas W. Dubensky is also the Chief Scientific Officer of Aduro Biotech Inc and owns about 7,980 shares of Aduro Biotech Inc (ADRO) stock worth over $116,508. Details can be seen in Thomas W. Dubensky's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas W. Dubensky has not made any transactions after 2022-01-07 and currently still holds the listed stock(s).
Transaction Summary of Thomas W. Dubensky
Thomas W. Dubensky Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas W. Dubensky owns 4 companies in total, including Aduro Biotech Inc (ADRO) , Chinook Therapeutics Inc (KDNY) , and Tempest Therapeutics Inc (TPST) among others .
Click here to see the complete history of Thomas W. Dubensky’s form 4 insider trades.
Insider Ownership Summary of Thomas W. Dubensky
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADRO | Aduro Biotech Inc | 2017-08-11 | Chief Scientific Officer |
| KDNY | Chinook Therapeutics Inc | 2015-04-14 | Chief Scientific Officer |
| TPST | Tempest Therapeutics Inc | 2022-01-07 | director & President |
 | | 2022-08-18 | director |
Thomas W. Dubensky Latest Holdings Summary
Thomas W. Dubensky currently owns a total of 2 stocks. Among these stocks, Thomas W. Dubensky owns 113,343 shares of Tempest Therapeutics Inc (TPST) as of January 7, 2022, with a value of $418,236 and a weighting of 78.21%. Thomas W. Dubensky also owns 7,980 shares of Aduro Biotech Inc (ADRO) as of August 11, 2017, with a value of $116,508 and a weighting of 21.79%.
Latest Holdings of Thomas W. Dubensky
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TPST | Tempest Therapeutics Inc | 2022-01-07 | 113,343 | 3.69 | 418,236 |
| ADRO | Aduro Biotech Inc | 2017-08-11 | 7,980 | 14.60 | 116,508 |
Holding Weightings of Thomas W. Dubensky
Thomas W. Dubensky Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas W. Dubensky has made a total of 1 transactions in Tempest Therapeutics Inc (TPST) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tempest Therapeutics Inc is the acquisition of 2,000 shares on January 7, 2022, which cost Thomas W. Dubensky around $9,560.
According to the SEC Form 4 filings, Thomas W. Dubensky has made a total of 0 transactions in Aduro Biotech Inc (ADRO) over the past 5 years. The most-recent trade in Aduro Biotech Inc is the sale of 10,000 shares on August 11, 2017, which brought Thomas W. Dubensky around $569,000.
Insider Trading History of Thomas W. Dubensky
- 1
Thomas W. Dubensky Trading Performance
GuruFocus tracks the stock performance after each of Thomas W. Dubensky's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas W. Dubensky is -19.14%. GuruFocus also compares Thomas W. Dubensky's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas W. Dubensky within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas W. Dubensky's insider trading performs compared to the benchmark.
Performance of Thomas W. Dubensky
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -23.24 | | | | | |
| Relative Return to S&P 500(%) | -19.11 | | | | | |
Thomas W. Dubensky Ownership Network
Thomas W. Dubensky Owned Company Details
What does Aduro Biotech Inc do?
Who are the key executives at Aduro Biotech Inc?
Thomas W. Dubensky is the Chief Scientific Officer of Aduro Biotech Inc. Other key executives at Aduro Biotech Inc include director & President & CEO Eric Dobmeier , 10 percent owner Versant Voyageurs I, L.p. , and 10 percent owner Versant Voyageurs I Parallel, L.p. .
Aduro Biotech Inc (ADRO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aduro Biotech Inc (ADRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aduro Biotech Inc (ADRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aduro Biotech Inc (ADRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aduro Biotech Inc Insider Transactions
Thomas W. Dubensky Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas W. Dubensky. You might contact Thomas W. Dubensky via mailing address: C/o Aduro Biotech, Inc., 740 Heinz Avenue, Berkeley Ca 94710.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
